TGFB1 and breast carcinoma: In this current study, we expanded on our initial findings to demonstrate that emodin suppresses breast cancer cell EMT and reduces CSC/TIC numbers, through blocking the TGF-β1-mediated interaction between macrophages and breast cancer cells (Figure 7C).